Scott Kellen - Net Worth and Insider Trading
Scott Kellen Net Worth
The estimated net worth of Scott Kellen is at least $92,169 dollars as of 2024-05-24. Scott Kellen is the CFO and Secretary of DiaMedica Therapeutics Inc and owns about 32,290 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $92,027. Scott Kellen is also the COO, CFO, VP of Finance & Secy of Kips Bay Medical Inc and owns about 20,000 shares of Kips Bay Medical Inc (KIPS) stock worth over $142. Details can be seen in Scott Kellen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Kellen has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).
Transaction Summary of Scott Kellen
Scott Kellen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Kellen owns 3 companies in total, including DiaMedica Therapeutics Inc (DMAC) , Panbela Therapeutics Inc (PBLA) , and Kips Bay Medical Inc (KIPS) .
Click here to see the complete history of Scott Kellen’s form 4 insider trades.
Insider Ownership Summary of Scott Kellen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | CFO and Secretary |
| PBLA | Panbela Therapeutics Inc | 2015-10-01 | Chief Financial Officer |
| KIPS | Kips Bay Medical Inc | 2015-03-10 | COO & CFO & VP of Finance & Secy |
Scott Kellen Latest Holdings Summary
Scott Kellen currently owns a total of 2 stocks. Among these stocks, Scott Kellen owns 32,290 shares of DiaMedica Therapeutics Inc (DMAC) as of June 23, 2023, with a value of $92,027 and a weighting of 99.85%. Scott Kellen also owns 20,000 shares of Kips Bay Medical Inc (KIPS) as of August 30, 2013, with a value of $142 and a weighting of 0.15%.
Latest Holdings of Scott Kellen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | 32,290 | 2.85 | 92,027 |
| KIPS | Kips Bay Medical Inc | 2013-08-30 | 20,000 | 0.01 | 142 |
Holding Weightings of Scott Kellen
Scott Kellen Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Kellen has made a total of 4 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 10,000 shares on June 23, 2023, which cost Scott Kellen around $39,100.
According to the SEC Form 4 filings, Scott Kellen has made a total of 0 transactions in Kips Bay Medical Inc (KIPS) over the past 5 years. The most-recent trade in Kips Bay Medical Inc is the acquisition of 10,000 shares on August 30, 2013, which cost Scott Kellen around $7,800.
Insider Trading History of Scott Kellen
- 1
Scott Kellen Trading Performance
GuruFocus tracks the stock performance after each of Scott Kellen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Kellen is 17.12%. GuruFocus also compares Scott Kellen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Kellen within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Kellen's insider trading performs compared to the benchmark.
Performance of Scott Kellen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.62 | | | | | |
| Relative Return to S&P 500(%) | 14.63 | | | | | |
Scott Kellen Ownership Network
Scott Kellen Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Scott Kellen is the CFO and Secretary of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include director & President and CEO Dietrich John Pauls , 10 percent owner Ab Tomenterprise , and 10 percent owner Koch Thomas Von .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Scott Kellen made 1 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 10,000. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 215,000 shares made by Randall Michael Giuffre , a net purchase of 1,470,588 shares made by Koch Thomas Von , and a net purchase of 527,114 shares made by David J. Wambeke .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Scott Kellen Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Kellen. You might contact Scott Kellen via mailing address: 3405 Annapolis Lane, Suite 200, Minneapolis Mn 55447.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
